Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLendinvest Regulatory News (LINV)

Share Price Information for Lendinvest (LINV)

Share Price is delayed by 15 minutes
Get Live Data
24.50    -0.70 (-2.78%)
Bid:
24.00
Ask:
25.00
Spread: 1.00 (4.167%)
Market Cap: £34.70m
LINV Live PriceLast checked at - London Stock Exchange

Intraday Lendinvest Share Chart

LENDINVEST 8.25% NOTES 2030: OFFER CLOSING EARLY

11 Nov 2025 10:01

RNS Number : 0570H
Lendinvest PLC
11 November 2025
 

This is an advertisement and not a prospectus.

The information contained herein may only be released, published or distributed in the United Kingdom, the Isle of Man, Jersey and the Bailiwick of Guernsey in accordance with applicable regulatory requirements. The information contained herein is not for release, publication or distribution in or into the United States, Australia, Canada, Japan, South Africa, the European Economic Area or in any other jurisdiction where it is unlawful to distribute this document.

UK MiFIR retail investors, professional investors and ECPs target market - Manufacturer target market (UK MiFIR product governance) is eligible counterparties and professional clients (all distribution channels) and also retail clients (all distribution channels).

 

LENDINVEST SECURED INCOME III PLC 8.25% NOTES DUE 2030

Early Closure of Offer Period

LendInvest Secured Income III plc (the "Issuer") announces that the Offer Period for the LendInvest Secured Income III plc 8.25% Notes due 2030 (the "Notes") will close at 12pm (London time) on 11 November 2025, such time and date being earlier than the originally scheduled end to the Offer Period which was 4.00 pm (London time) on 11 November 2025.

The results of the offer will be specified in the Announcement of Results and Final Terms Confirmation, which is expected to be made on or around 12 November 2025.

Defined terms used herein shall have the meanings attributed to them in the Final Terms dated 14 October 2025 in relation to the Notes.

-ENDS-

 

For further information, please contact:

LendInvest  

Hugo Davies, Chief Capital Officer & Managing Director LI Mortgages

Frederick Newman, Director of Treasury MarketsChris Semple, Head of Corporate Communications & Investor Relations

Email: investorrelations@lendinvest.com 

Telephone:

+44 (0)20 3747 4187

Allia C&C Ltd

Mark Glowrey

Telephone:

+44 (0)20 3039 3465

 

This announcement is an advertisement within the meaning of Article 2(k) of Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended, the "UK Prospectus Regulation") and is not a prospectus for the purposes of the UK Prospectus Regulation. A Base Prospectus dated 13 October 2025 (the "Base Prospectus") and Final Terms dated 14 October 2025 relating to the Notes have been prepared and made available to the public in accordance with the UK Prospectus Regulation. The Base Prospectus and Final Terms are available on the website of LendInvest plc (https://www.lendinvest.com/capital/listed-bond-5).

The Base Prospectus has been approved by the Financial Conduct Authority (the "FCA") as competent authority under the UK Prospectus Regulation. The FCA only approves the Prospectus as meeting the standards of completeness, comprehensibility and consistency imposed by the UK Prospectus Regulation. Such approval should not be considered as an endorsement of LendInvest plc, LendInvest Secured Income III plc or the quality of the Notes that are the subject of the Base Prospectus.

Potential investors should read the Base Prospectus and Final Terms before making an investment decision in order to fully understand the potential risks and rewards associated with the decision to invest in the Notes. Investors should not subscribe for any notes referred to in this announcement except on the basis of information in the Base Prospectus and Final Terms.

The restriction on financial promotions contained in section 21(1) of the Financial Services and Markets Act 2000 does not apply to this announcement by virtue of article 70(1A) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended.

The offering and the distribution of this announcement and other information in connection with the offer in certain jurisdictions may be restricted by law and persons into whose possession any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This announcement does not constitute or form part of any offer or invitation to sell, or any solicitation of any offer to purchase any Notes. Any purchase of Notes pursuant to the offer should only be made on the basis of the information contained in the Base Prospectus and Final Terms.

The Notes have not been and will not be registered under the United States Securities Act of 1933 (as amended, the "Securities Act") and, subject to certain exceptions, may not be offered or sold within the United States or to, or for the account or benefit of, United States persons. The Notes are being offered and sold outside of the United States in reliance on Regulation S of the Securities Act.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
OUPPKDBKKBDDKDD
Date   Source Headline
29th Apr 20268:00 amRNSHolding(s) in Company
23rd Apr 20267:00 amRNSLendInvest FY26 Trading Update
28th Jan 20264:18 pmRNSHolding(s) in Company
28th Jan 20264:13 pmRNSDirector/PDMR Shareholding
28th Jan 20264:11 pmRNSDirector/PDMR Shareholding
26th Jan 20267:00 amRNSLendInvest announces FuM has increased to £5.44bn
6th Jan 20261:38 pmRNSHolding(s) in Company
18th Dec 20255:51 pmRNSHolding(s) in Company
18th Dec 20255:51 pmRNSHolding(s) in Company
18th Dec 20255:44 pmRNSDirector/PDMR Shareholding
18th Dec 20255:44 pmRNSDirector/PDMR Shareholding
17th Dec 20255:38 pmRNSDirector/PDMR Shareholding
9th Dec 20257:00 amRNSReplacement LendInvest H1 FY26 Financial Statement
8th Dec 20257:00 amRNSLendInvest plc H1 FY26 Interim Financial Statement
14th Nov 20256:00 pmRNSPublication of Amended and Restated Final Terms
14th Nov 20252:49 pmRNSLendInvest III Notes 2030: Amended Final Terms
12th Nov 202511:20 amRNSLendInvest III 8.25% Notes: Results & Final Terms
11th Nov 202510:01 amRNSLENDINVEST 8.25% NOTES 2030: OFFER CLOSING EARLY
4th Nov 20259:29 amRNSLendInvest: Notification of Major Holdings change
4th Nov 20259:26 amRNSLendInvest: Notification of major holdings change
28th Oct 202512:23 pmRNSLendInvest Closes £310m RMBS Securitisation
14th Oct 20255:11 pmRNSLENDINVEST ANNOUNCE LAUNCH OF 8.25% NOTES DUE 2030
14th Oct 20254:56 pmRNSExchange Offer Memorandum, Prospectus & Final Term
14th Oct 202510:49 amRNSPublication of a Base Prospectus
2nd Oct 20251:11 pmRNSLendInvest Secured Income 3 Roadshow Announcement
9th Sep 20255:06 pmRNSAGM Statement
7th Aug 20251:00 pmRNSPublication of FY25 Annual Report & notice of AGM
31st Jul 20257:00 amRNSDirector/PDMR Shareholding
21st Jul 20257:43 amRNSAnnual Financial Report
3rd Mar 20257:00 amRNSLendInvest Board Changes
27th Jan 20257:00 amRNSLendInvest grows Funds under Management to £5.14bn
17th Dec 20243:49 pmRNSChange of Registered Office
9th Dec 20247:00 amRNSHalf-year Report
7th Nov 20247:00 amRNSLendInvest Closes £285M UK Mortgage Securitisation
5th Nov 20244:28 pmRNSDirector/PDMR Shareholding
25th Oct 20249:31 amRNSHolding(s) in Company
25th Oct 20249:30 amRNSDirector/PDMR Notification
21st Oct 20247:00 amRNSLendInvest Secures £300m from BNP, Barclays, HSBC
24th Sep 20242:42 pmRNSResult of AGM
10th Sep 20247:00 amRNSLendInvest signs £1.5bn funding deal with JPMorgan
6th Sep 202411:53 amRNSPDMR Dealing
20th Aug 202411:42 amRNSIssue of Shares to EBT and Total Voting Rights
14th Aug 202411:32 amRNSPublication of Annual Report and Notice of AGM
31st Jul 20247:00 amRNSBoard Changes
24th Jul 20247:05 amRNSLendInvest plc Full Year Financial Results FY24
17th Jun 20247:00 amRNSUpdate on FY24 guidance
4th Jun 20249:58 amRNSBoard Changes
4th Jun 20247:01 amRNSLendInvest successfully closes funding transaction
4th Jun 20247:00 amRNSBoard Changes
18th Apr 20247:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.